StockNews.com began coverage on shares of vTv Therapeutics (NASDAQ:VTVT – Free Report) in a research note published on Wednesday morning. The brokerage issued a hold rating on the biotechnology company’s stock. vTv Therapeutics Price Performance VTVT stock opened at $0.50 on Wednesday. The stock’s 50 day moving average is $0.71 and its 200-day moving average […]